pocketful logo light
pocketful logo light
Bliss GVS Pharma Ltd logo

Bliss GVS Pharma Ltd

NSE: BLISSGVS BSE: 506197

₹694.60

(5.00%)

Mon, 28 Sept 2026, 02:01 am

Bliss GVS Pharma Share Price Live Chart

1 Day

(5.00%)

No Result Found

Summary

  • Market Cap (in Cr)

    4493.92

  • Net Profit (in Cr)

    90.26

  • P/B

    1.18

  • Sector P/E

    33.76

  • P/E

    14.69

  • EV/EBITDA

    6.82

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    8.95

  • ROCE

    12.09

  • Debt/Equity

    0.09

  • EPS (TTM)

    12.36

  • Dividend Yield

    0.24

  • Book Value

    112.76

  • Interest Cover

    16.47

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are thoroughly covered by earnings (10.3x coverage).
  • Bliss GVS Pharma's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Bliss GVS Pharma is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Bliss GVS Pharma is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Bliss GVS Pharma's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • High level of physical assets or inventory.
  • Shibroor's remuneration is higher than average for companies of similar size in India.
  • Bliss GVS Pharma is not covered by any analysts.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters35.3635.3635.3935.4435.29
FII10.4514.5413.2712.6513.18
DII5.045.785.986.546.55
Public49.1544.3245.3645.3644.98
Government00000

Read More

Technical Analysis

RSI

63.70

MACD

34.69

50 DMA

571.60

200 DMA

349.38

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic875.50720.55668.65565.60513.70410.65255.70
Fibonacci720.55661.36624.79565.60506.41469.84410.65
Camarilla659.36645.16630.95565.60602.55588.34574.14

Pivots Level: Classic

R3

+309.90

875.50

R2

+154.95

720.55

R1

+103.05

668.65

565.60
565.60
Pivot Point
LTP: 704.70

S1

-51.90

513.70

S2

-154.95

410.65

S3

-309.90

255.70

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    687.59

  • 20-EMA

    664.66

  • 30-EMA

    639.29

  • 50-EMA

    595.13

  • 100-EMA

    509.52

  • 200-EMA

    402.86

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
12 May 2026agm
12 May 2026board-meetingsAccounts, Final Dividend
10 Feb 2026dividend₹0.50 Dividend /Share18 Feb 2026
10 Feb 2026board-meetingsQuarterly Results, Interim Dividend
18 Jan 2026dividendInterim Dividend - Re 0.50 Per Share18 Feb 2026
06 Nov 2025board-meetingsQuarterly Results
24 Jun 2025dividendFinal Dividend - Rs. - 0.524 Jul 2025
12 May 2025agm
12 May 2025dividend₹0.50 Dividend /Share24 Jul 2025
18 Jun 2024dividendAnnual General Meeting/Dividend - Rs 0.50 Per Share19 Jul 2024

Read More

Peer Comparison

Bliss GVS Pharma Ltd logo

Bliss GVS Pharma Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Bliss GVS Pharma Ltd About

Bliss GVS Pharma is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company is one of among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1984

Headquarters

CEO

Nandkumar Kashinath Chodankar

Employees

Contact

Website icon

Website

http://www.blissgvs.com

Email icon

Email

cs@blissgvs.com; info@blissgvs.com

Phone icon

Phone

91-22-42160000

Location icon

Location

102 Hyde Park Sakivihar Road, Andheri East, Mumbai, Maharashtra, 400072

Read More

Bliss GVS Pharma Ltd Company History

YearHistory
2012
  • Company has acquired 70% management stake in the Company M/s. Kremoint Pharma Private Limited
2013
  • Bliss GVS Pharma Ltd recommended a dividend of 40%
  • Bliss GVS receives recognition for its Research & Development Lab from the Department of Scientific & Industrial Research (DSIR), Government of India.
2014
  • Bliss GVS is named in Moneylife magazine's 'Wealth Creators 2004-2013' list
  • Bliss GVS Wins - Outstanding Exports Award.
2015
  • Bliss GVS Pharma wins Healthcare Services contract in Kenya
2016
  • Bliss GVS Pharma arm wins $111 mn contract from Kenyan firm.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
HRTI PRIVATE LIMITEDbulkSell562933420.4929 May 2026
HRTI PRIVATE LIMITEDbulkBuy457998419.2629 May 2026
SHAILESH SHIVKUMAR DALMIAbulkSell1008910317.6425 May 2026
HRTI PRIVATE LIMITEDbulkSell581292224.8625 Mar 2026
HRTI PRIVATE LIMITEDbulkBuy517506224.2625 Mar 2026
RATNABALI EQUITY PRIVATE LIMITEDbulkSell717102212.1120 Mar 2026
RATNABALI EQUITY PRIVATE LIMITEDbulkBuy717000212.5620 Mar 2026
MATEUS LTDbulkBuy933978210.8119 Mar 2026
ARIAN INVESTMENT LTDbulkSell1000000210.8219 Mar 2026
MANSUKH SECURITIES & FINANCE LIMITEDbulkSell620900216.2224 Feb 2026

Read More

Bliss GVS Pharma Ltd News

Bliss GVS Pharma approves director appointment

Bliss GVS Pharma shareholders approved the appointment of Santosh Parab as Non-Executive Non-Independent Director via postal ballot with 97.04% votes in favour.

22 Sept 2026

companies

Bliss GVS Pharma accepts Sachin Saboo's resignation

Bliss GVS Pharma Limited has accepted the resignation of Sachin Saboo, General Manager – Regulatory & Clinical, effective July 24, 2026. He cited professional aspirations as the reason for his departure.

25 Jul 2026

companies

Anupam Rasayan adds Mates Visa as PAC

Anupam Rasayan India Ltd designated Mates Visa Consultancy Pvt Ltd as a person acting in concert for its open offer to acquire 26% of Bliss GVS Pharma Ltd.

19 Jul 2026

companies

Bliss GVS Pharma declares final dividend

Bliss GVS Pharma declared a final dividend of Re. 1.00 per share for FY26 at its 41st AGM. Shareholders approved financial statements and director re-appointment.

15 Jul 2026

companies

Bliss GVS Pharma appoints new CEO and director

Bliss GVS Pharma appointed Rahul Adakmol as CEO effective July 15, 2026, and Santosh Parab as Additional Director. Narsimha Kamath stepped down as CEO.

03 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Bliss GVS Pharma Ltd?

    As of 28/09/2026 at 7:31 AM, Bliss GVS Pharma Ltd shares are trading at ₹694.60.

  • 2.What is the market cap. of Bliss GVS Pharma Ltd?

    As of 28/09/2026, the market capitalization of Bliss GVS Pharma Ltd is ₹6,988.13 crore.

  • 3.When was Bliss GVS Pharma Ltd founded?

    Bliss GVS Pharma Ltd was founded in 1984.

  • 4.What are the P/E and P/B ratios of Bliss GVS Pharma Ltd?

    As of 28/09/2026, Bliss GVS Pharma Ltd has a P/E ratio of 55.08 and a P/B ratio of 1.18.

  • 5.How can I buy shares of Bliss GVS Pharma Ltd?

    You can buy shares of Bliss GVS Pharma Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Bliss GVS Pharma Ltd?

    As of March,2026, promoters hold 35.36% in Bliss GVS Pharma Ltd, while FIIs, DIIs and public shareholders hold 10.45%, 5.04% and 49.15%, respectively.

  • 7.Does Bliss GVS Pharma Ltd pay dividends?

    Yes, Bliss GVS Pharma Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹0.50 Dividend /Share per share.

  • 8.What is the dividend yield of Bliss GVS Pharma Ltd?

    As of 28 September, 2026, the dividend yield of Bliss GVS Pharma Ltd stands at 0.22%.

  • 9.What are the latest financial results of Bliss GVS Pharma Ltd?

    For January,2024, Bliss GVS Pharma Ltd reported revenue of ₹802.00 crore and a net profit of ₹84.30 crore.

  • 10.What is the Stock symbol of Bliss GVS Pharma Ltd?

    BLISSGVS is the stock symbol of Bliss GVS Pharma Ltd.

  • 11.Who is the CEO of Bliss GVS Pharma Ltd?

    The CEO of Bliss GVS Pharma Ltd is Nandkumar Kashinath Chodankar.